Author: Derrick Freeman

Webcast Teaches Physicians About Advances in Liver Disease

by

OSU Wexner Medical Center logo Webcast Teaches Physicians About Advances in Liver Disease. Last summer, experts from around the world worked together to rename Nonalcoholic fatty liver disease into Metabolic dysfunction-associated steatotic liver disease or MASLD. And earlier this year at the end of March 2024, the FDA approved the first drug to treat MASLD. Meanwhile another promising agent is already in the pipeline, currently undergoing phase 3 clinical trials.

To share more about the advances in some of the most common liver conditions including MASLD, autoimmune hepatitis, and Hepatocellular carcinoma, We’ve invited one of Ohio State University’s Transplant Hepatology experts. We are pleased to introduce Assistant Professor of Gastroenterology and Hepatology Dr Vivek Mendiratta.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand steatotic liver disease including diagnosis, management, and pharmacologic treatment options.
  • Learn about the newest advances in hepatocellular carcinoma including the role of combination therapy, novel biomarkers, and liver transplantation.

You’ll also learn about the following:

  • Treatment & Monitoring
  • Weight Loss
  • Liver Transplantation

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Watch Webcast to Learn Latest on CPT Coding Updates and Tips

by

OSU Wexner Medical Center logo Watch Webcast to Learn Latest on CPT Coding Updates and Tips. On this webcast, we’re going to be focusing on the most common services, the codes for evaluation and management or E and M services. Joining us in the studio to discuss inpatient coding and billing is hospitalist and Assistant Professor of Internal Medicine, Dr. Eric Nolan. And then to discuss ambulatory coding and billing, we have general internist and Associate Professor of Internal Medicine, Dr. Jodi Grandominico.

What you’ll learn in this webcast

  • Learn ways to optimize the accuracy of documentation and billing
  • Learn how to optimize documentation, diagnosis, and problem association to accurately reflect the patient’s complexity in their Diagnosis Related Group (DRG)
  • Understand ambulatory coding updates
  • Document less
  • Big wins for primary care!
  • Get paid for the work you (already) do

You’ll also learn about the following:

  • New changes to inpatient CPT coding
  • Improvements to primary care reimbursement

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches About Managing Complications of Chemotherapy

by

OSU Wexner Medical Center logo CME Webcast Teaches About Managing Complications of Chemotherapy. With more and more patients being exposed to cancer treatments, it is important for us to be familiar with the side effects and toxicities of modern chemotherapy agents. May is National Cancer Research Month. For today’s topic, We’ve invited one of Ohio State University James cancer hospitals Oncology experts. On this webcast, we get to welcome Associate Professor of Oncology Dr Edmund Folefac, who specializes in treating genitourinary cancers. In addition he is widely published cancer researcher.

What you’ll learn in this webcast

  • As a result of this educational activity, webcast participants will be able to:
  • Become familiar with common adverse reactions of newer chemotherapy agents including tyrosine kinase inhibitors, immunotherapy, and antibody drug conjugates.

Understand the basic principles of treating mild, moderate and severe toxicities to chemotherapy.

You’ll also learn about the following:

  • Evolution of Cancer Therapies
  • Red Flags
  • General Wellness
  • Long Term Therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Teach on Anticoagulant and Antiplatelet Update

by

OSU Wexner Medical Center logo Experts Teach on Anticoagulant and Antiplatelet Update. Aspirin is now used to prevent and treat cardiovascular disease due to its antithrombotic effects. It even prevents cancer! Our understanding of Aspirin and it’s benefits and harms has advanced tremendously in recent years. We also have several new antiplatelet and anticoagulant options.

To share the latest research and guidelines for using anticoagulant and antiplatelet agents, We’ve invited two of Ohio State University’s Pharmacology experts. We are pleased to introduce Doctor of Pharmacy Alyssa Rinaldi who is the Outpatient Anticoagulation Clinic lead & Danielle Blais who is a Doctor of Pharmacy and Lead Specialty Practice Pharmacist of OSU Cardiology.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Re-assess historical “gray areas” for DOAC use including in obesity, mechanical heart vales, antiphospholipid syndrome (APS) mechanical heart valves, and treatment of left ventricular (LV) thrombus
  • Explore the anticoagulation pipeline including Factor XI inhibitors
  • Describe the role of aspirin and oral P2Y12 inhibitors for patients with chronic coronary disease or acute coronary syndromes with or without percutaneous coronary intervention
  • Evaluate the advantages and disadvantages of the different P2Y12
    inhibitors

You’ll also learn about the following:

  • Single Antiplatelet Therapy
  • Pre-procedure Medication recommendations

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Common Skin Complaints and Updates on CME Webcast

by

OSU Wexner Medical Center logo Learn About Common Skin Complaints and Updates on CME Webcast. Common skin conditions like acne or rosacea are often considered a nuisance rather than a serious medical condition. But the truth is these benign skin conditions can have a marked psychological impact on patients. Acne for example is linked with higher rates of anxiety, depression and low self-esteem. It can decrease a person’s participation in activities including sports, school and even the workforce. So, its important to take these concerns seriously and offer treatment early.

To discuss common benign skin conditions we may see in our practice and how to treat them, We have invited one of Ohio State University’s Dermatology experts. Dr Natalie Spaccarelli is an Assistant Professor of Dermatology. She is the director of pigmented lesions and high risk skin cancer clinic as well as general dermatology at the Columbus VA.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Increase comfort recognizing and managing patients with straight-forward cases of acne, rosacea, seborrheic dermatitis, tinea, intertrigo, scabies, and herpes.
  • Increase comfort discussing sunscreen recommendations with patients.

You’ll also learn about the following:

  • Acne Treatment
  • Contraindications

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.